Nasus Pharma Ltd. Ordinary Shares (NSRX)
Stock · AMEX · Health Care
$4.1as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$2.93
Industry
Biotechnology: Pharmaceutical Preparations
About NSRX
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Nalo…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 7
- Website
- www.nasuspharma.com
Fundamentals
- 1-day range
- $3.2$3.64
- Market cap
- $37.36M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.72
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 26.9K
52-week range
$1.98$9.99
Forecasts
3 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$22
+436.6%
Median
$19
+363.4%
Low
$18
+339.0%
Nasus Pharma Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NSRXNasus Pharma Ltd. Ordinary Shares$4.1▲ 0.00%Market cap $37.36MP/E —$1.98$9.99
- APLMApollomics Inc. Class A Ordinary Shares$26.6▲ 1.14%Market cap $37.33MP/E —$3.66$42.12
- ENLVEnlivex Ltd. Ordinary Shares$1.35▼ 8.47%Market cap $36.53MP/E 0.02$1.35$27.15
- NNVCNanoViricides Inc. Common Stock$1.24▼ 3.12%Market cap $39.37MP/E —$0.85$2.23
- IXHLIncannex Healthcare Inc. Common Stock$3.61▼ 2.17%Market cap $35.06MP/E —$2.49$20.64
- HYPDHyperion DeFi Inc. Common Stock$3.25▼ 10.36%Market cap $40.32MP/E —$2.34$15
- LTRNLantern Pharma Inc. Common Stock$2.08▼ 3.70%Market cap $33.30MP/E —$1.11$4.7
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NSRX Nasus Pharma Ltd. Ordinary Shares | $37.36M | — | $4.1 | ▲ 0.00% | $1.98$9.99 |
| APLM Apollomics Inc. Class A Ordinary Shares | $37.33M | — | $26.6 | ▲ 1.14% | $3.66$42.12 |
| ENLV Enlivex Ltd. Ordinary Shares | $36.53M | 0.02 | $1.35 | ▼ 8.47% | $1.35$27.15 |
| NNVC NanoViricides Inc. Common Stock | $39.37M | — | $1.24 | ▼ 3.12% | $0.85$2.23 |
| IXHL Incannex Healthcare Inc. Common Stock | $35.06M | — | $3.61 | ▼ 2.17% | $2.49$20.64 |
| HYPD Hyperion DeFi Inc. Common Stock | $40.32M | — | $3.25 | ▼ 10.36% | $2.34$15 |
| LTRN Lantern Pharma Inc. Common Stock | $33.30M | — | $2.08 | ▼ 3.70% | $1.11$4.7 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Nasus Pharma H1 EPS $(0.54) Misses $(0.20) EstimateBenzinga · 8/17/2026
Insider Activity
Insider Actions →Acquired
24.4K
Disposed
0
- Dan Benjamin Teleman · June 17, 2026 · Buy6.5K @ $3.1
- Dan Benjamin Teleman · April 22, 2026 · Buy2.9K @ $3.76
- Dan Benjamin Teleman · March 31, 2026 · Buy15.0K @ $2.04
See the full, filterable feed with live charts on the MarketWall dashboard.